… 13) than in SSc patients with normal IL-17 production (7.6 … Elevated serum levels of
interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 1997;24:328–32. …

… interleukin-12 and augmenting interleukin-10 production. To examine the effects of interferon-β
on the interleukin-12/interleukin-10 axis in multiple sclerosis… cells from patients beginning …

… RNA probes for IL-13 was performed on lymph node biopsies from four … patients newly
diagnosed with classical nodular sclerosis HD. The diagnosis was based on the nodular sclerosis …

… -у to MS patients increased the exacerbation rate of their disease,13 … MS=multiple sclerosis
patients; HC=healthy controls; OND=patients … Interleukin-12 production in multiple sclerosis …

… with 20 ng/ml interleukin-13 (IL-13) or without IL-13 stimulation (control). f, Plasma IL… 13
concentration in healthy controls, dcSSc patients, lcSSc patients without PAH, and lcSSc patients …

… We have detected IL-12 in the sera from six out of 13 patients with NIND. The events leading
to potential activation of macrophages or B cells, which are the predominant source of IL-12 …

… If this will be the case, serum molecules showing the attitude to increase in SSc in parallel
with the onset and progression of skin sclerosis, like sICAM-1, CCL2, CXCL8 and IL-13, could …

… Cytokines are implicated in the immunopathogenesis of multiple sclerosis (MS). Interleukin
(IL)-33, one of the recently discovered members of the IL-1 superfamily, is a dual functional …

… that IL-13 is an important mediator in the pathogenesis of asthma 22,23,24,25. IL-13 has
also been implicated in the pathogenesis of hepatic fibrosis, progressive systemic sclerosis, …

… The 13 MS patients who were analyzed in this study were the Amsterdam placebo controls
of this multi-Centre trial.The most relevant inclusion criteria were clinically definite19 RR or …